Clinical Trial Update: GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a GnRH antagonist for the treatment of early ovarian hyperstimulation syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Ovarian Hyperstimulation Syndrome, Effects of Gonadotropin | Phase 3 | Status: COMPLETED